RGC
RGC
NASDAQ · Pharmaceuticals

Regencell Bioscience Holding

Mid-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks
$5.92
+0.13 (+2.25%)
As of Sep 21, 9:43 PM ET ·
RGC News2 articles
Regencell Bioscience Shares Slide 63% Below May Offering Price
Regencell Bioscience (NASDAQ:RGC) dropped 6.6% to $7.50, remaining 63.1% below its May offering price, despite a brief intraday rebound. Biotech ETFs gained.
Markets
Regencell Bioscience Surges But Still 60% Below May Offering Price
Regencell Bioscience (RGC) shares surged 31.9% on Wednesday, yet still trade 60.4% below the May direct offering price. The stark rebound underscores the volatility and fundamental challenges facing the pre-revenue biotech.
Markets